Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2026-04-22 @ 8:29 PM
Study NCT ID:
NCT05689450
Status:
COMPLETED
Last Update Posted:
2024-02-21
First Post:
2023-01-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder
Sponsor:
University Hospital, Basel, Switzerland
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Febrile Neutropenia (FN) | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Amikacin | View |
| None | Hematological disorder | View |
| None | Aminoglycoside (AG) | View |
| None | Area under the curve (AUC) | View |
| None | Acute kidney injury (AKI) | View |
| None | Pharmacokinetics and pharmacodynamics (PKPD) analysis | View |
| None | Peak serum concentration (Cmax) | View |
| None | Trough serum concentration (Cmin) | View |
| None | Renal toxicity | View |
| None | Pharmacological target attainment | View |
| None | Amikacin concentration | View |